A Trial Of Differentiating Hepatocellular Carcinoma From Analogous Lesions In Rat Experimental Tumor Models Using Iron Colloid Enhanced MR Imaging.

使用铁胶体增强 MR 成像在大鼠实验肿瘤模型中区分肝细胞癌和类似病变的试验。

基本信息

  • 批准号:
    07671004
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

To demonstrate the usefulness of iron colloid-enhanced MR images (MRI) in differentiating between hepatocellular carcinoma (HCC) and hyperplastic nodular lesions (HN), microautoradiograms were prepared after administration of chondroitin sulfate iron colloid (CSIC) labelled with 59Fe in rat tumor models. Twenty rats were divided into 3 groups, normal, HCC and HN groups. In the HCC,0.06% 3'-Mmethydiaminobenzine tetrahydro-chloride (DAB) was administered for 3 consecutive months for tumor induction. In the HN,0.025% acetylaminofluorene (AAF) was intermittently administered for 4 months. HCC models were divided into 2 types, well-differentiated HCC (HCC-W), moderately to poorly-differentiated HCC (HCC-MP). By quantitative analysis using microautoradiography, the number of Kupffer cells per field of view was calculated. Furthermore, the images on the dark fields were transferred to an image processing system. A photosensitized area ratio (PAR) was calculated. These ratios were compared among groups.There was no significant difference in either the number of Kupffer cells or PAR between HN and normal liver tissues. In HCC-W,Kupffer cells were also present. However, their distribution was scattered, and the number of Kupffer cells and the PAR were significantly lower than those in normal liver tissues. In HCC-MP,the distribution of Kupffer cells was also scattered. Both the number of Kupffer cells and the PAR were significantly lower than those in HCC-W.In conclusion, iron colloid-enhanced MRI is useful for differentiating HCC from HN and diagnosing the degree of differentiation of HCC.
为了证明铁胶体增强磁共振成像(MRI)在区分肝细胞癌(HCC)和增生性结节性病变(HN)中的有用性,在大鼠肿瘤模型中给予59 Fe标记的硫酸软骨素铁胶体(CSIC)后制备了显微放射自显影图。将20只大鼠分为正常组、肝癌组和HN组。在HCC中,连续3个月给予0.06%3 '-甲基二氨基苯四氢氯化物(DAB)诱导肿瘤。HN组间断给予0.025%乙酰氨基芴(AAF)4个月。HCC模型分为高分化HCC(HCC-W)和中分化至低分化HCC(HCC-MP)两种类型。通过使用显微放射自显影术的定量分析,计算每个视野的枯否细胞数量。此外,将暗场上的图像转移到图像处理系统。计算光敏面积比(PAR)。各组间比较,HN与正常肝组织间枯否细胞数及PAR均无显著性差异。在HCC-W中,还存在枯否细胞。但其分布较分散,枯否细胞数量和PAR均明显低于正常肝组织。在HCC-MP中,枯否细胞也呈散在分布。Kupffer细胞数量和PAR均显著低于HCC-W。结论:铁胶增强MRI有助于HCC与HN的鉴别及HCC分化程度的诊断。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yuji Suto: "Usefulness of iron colloid-enhanced MRI in differentiating experimental hepatocellular carcinoma from hyperplastic nodule in rats : analysis by microautoradiography." Br J Radiol. 69. 1139-1144 (1996)
Yuji Suto:“铁胶体增强 MRI 在区分大鼠实验性肝细胞癌和增生性结节中的作用:通过显微放射自显影进行分析。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
YUJI SUTO: "Usefulness of Iron Collid-Enhanced MRI in Differentiating Experimental Hepatocellular Carcinoma from Hyperplastic Nodule in Rats : Analysis by Microautoradiography" Br J Radiol. 69-12. 1139-1144 (1996)
YUJI SUTO:“铁胶体增强 MRI 在区分大鼠实验性肝细胞癌与增生性结节中的作用:通过显微放射自显影进行分析”Br J Radiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuji Suto: "Usefulness of iron colloid-enhanced MRI in differentiating experimental hepatocellular carcinoma from hyperplastic nodule in rats:analysis by microautoradiography." Br J Radiol. 69・12. 1139-1144 (1996)
Yuji Suto:“铁胶体增强 MRI 在区分大鼠实验性肝细胞癌和增生性结节中的作用:通过显微放射自显影进行分析。” 69・12。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUTO Yuji其他文献

SUTO Yuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

肝受体类似物(Liver Receptor Homolog 1, LRH 1)在雌鼠生殖过程中的作用及其机制
  • 批准号:
    31172040
  • 批准年份:
    2011
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目

相似海外基金

HoloSurge: Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时指导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
  • 批准号:
    10103131
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    EU-Funded
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
  • 批准号:
    MR/X008827/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Research Grant
Atypical Chemokine Receptors orchestrate changes in vascular patterning during fibrotic liver disease via Endothelial-to-Mesenchymal Transition.
非典型趋化因子受体通过内皮-间质转化协调纤维化肝病期间血管模式的变化。
  • 批准号:
    MR/Y013751/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Research Grant
Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干​​扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
  • 批准号:
    10092670
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    EU-Funded
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
  • 批准号:
    10109933
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    EU-Funded
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
  • 批准号:
    10087822
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    EU-Funded
HoloSurge:Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时引导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
  • 批准号:
    10109943
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    EU-Funded
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)
多能干细胞衍生的肝细胞治疗肝衰竭(PUSH for LIFE)
  • 批准号:
    MR/Z503940/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Research Grant
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
  • 批准号:
    10073169
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Collaborative R&D
Quantitative ultrasound to improve detection and diagnosis of liver cancer
定量超声改善肝癌的检测和诊断
  • 批准号:
    490038
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了